37 articles found

Provider review

CoreAge Rx micronized progesterone review: what each word establishes

A close reading of the advertised capsule, its compounding statement, starting price, and the product details still needed.

Comparison

Best micronized progesterone options to compare: care, product, and pharmacy

CoreAge holds the disclosed commercial first position. The comparison separates a prescribing offer, a named capsule, and a pharmacy listing.

Product review

Prometrium micronized progesterone review: identity, form, and label evidence

What the current named-product label establishes, from oral capsule identity to the limits of micronization and approval language.

Pharmacy review

Cost Plus Drugs progesterone review: the generic listing and pharmacy questions

A current catalog price can help compare dispensing costs, but it does not identify a guaranteed manufacturer or include menopause prescribing care.

Guide

What micronized progesterone means: one physical detail, several separate questions

Understand the particle-size term without turning it into a promise about your dose, absorption, safety or treatment outcome.

Guide

Bioidentical progesterone and FDA approval answer different questions

Separate the hormone's chemical identity from the evidence and regulatory status of the medicine that contains it.

Guide

Progesterone, progestogen and progestin: connect the word to the actual medicine

A guide to hormone-family terms, exact ingredient names and why the preparation in a study matters when interpreting a safety claim.

Guide

Oral, vaginal and skin progesterone: match the evidence to the route

Named product labels show why the same hormone ingredient cannot make a capsule, vaginal insert and skin cream interchangeable.

Provider review

Alloy micronized progesterone review: three labels beside one unidentified pill

Bioidentical, FDA-approved and pill are different claims; Alloy’s product page does not provide the complete dispensing identity that would connect them.

Provider review

Midi micronized progesterone review: read the powder, capsule and compounding statement separately

Midi names an oral compounded product and its inactive ingredients; the description is more specific than a hormone category but still has clear verification limits.

Provider review

Evernow micronized progesterone review: a treatment page is not a product specification

Evernow verifies access to progesterone care, but its public treatment description does not settle a capsule brand, complete formulation or regulatory record.

Provider review

Winona micronized progesterone review: an active ingredient is not the entire formula

Winona’s capsule and combination cream provide different ingredient records, while its FAQ uses conflicting language about approval and compounding.

Provider review

Gennev micronized progesterone review: prescribing access is not a confirmed formulation

Gennev’s consultation and pharmacy pathway are documented, while an oral product, particle-size description and complete ingredient record remain unconfirmed.

Provider review

MyMenopauseRx micronized progesterone review: a shared list of forms needs careful reading

The provider names estradiol and progesterone alongside several delivery forms, but that collective description does not assign every form to each hormone.

Provider review

Pandia Health micronized progesterone review: a brand entry and a generic heading are different records

Pandia names Prometrium and progesterone capsules, but a catalog position does not verify stock, a selected manufacturer or the terms of an individual order.

Provider review

Stella micronized progesterone review: a capsule in a sample plan is still unnamed

Stella’s US clinic illustrates care with progesterone capsules, but the example does not identify a manufacturer, complete formula or product-specific approval record.

Provider review

Wisp micronized progesterone review: a shared heading contains different medicines

Wisp lists micronized progesterone and Provera within its menopause options; their neighboring placement does not make their active ingredients or labels interchangeable.

Provider review

Thrivelab review: what its compounding description establishes

Thrivelab identifies a compounded-care pathway. Its pharmacy wording and historical medicine table leave different questions about the actual progesterone preparation.

Provider review

Defy Medical review: reading a hormone menu without inventing a product

Defy’s menopause and hormone pages establish a care service. Its route menu and average spending figures do not identify a particular micronized progesterone prescription.

Provider review

BodyLogicMD review: a network name is not a formulation

BodyLogicMD describes bioidentical hormone care and a membership. Neither a clinician directory nor a hormone panel identifies the progesterone that a patient would receive.

Provider review

Renew Youth review: what “natural” leaves unanswered

Renew’s progesterone discussion uses reassuring origin and benefit language. Its care offer, route discussion and introductory charge need separate interpretation.

Provider review

Hone Health review: a compounded capsule is a specific category, not an approved generic

Hone names a compounded oral capsule and an estimated medicine charge. That helps identify the offer while leaving formulation, evidence and complete membership costs distinct.

Provider review

Lifeforce review: how much does its Micronized Progesterone title tell you?

Lifeforce names micronized progesterone, but its product details and plan descriptions leave important gaps, including an ambiguous ingredient warning and conflicting prices.

Provider review

Fountain review: a hormone kit is a purchase description

Fountain names progesterone within a care package. Its kit wording, week-based billing and pharmacy terms do not establish a particular micronized medicine.

Provider review

Alpha Hormones review: an approved oral category still needs a product name

Alpha explicitly describes FDA-approved oral micronized progesterone. The category is useful, but the exact manufacturer, ingredients and selected membership terms remain separate questions.

Provider review

Newson Clinic review: UK hormone care and the missing product identity

Newson names progesterone within UK consultations. An independently labeled UK capsule helps explain terminology, but does not prove what this clinic prescribes or supplies.

Provider review

Duke Health micronized progesterone review: what “regulated” leaves unidentified

Duke names progesterone and regulated bioidentical hormone therapy. Those words describe its treatment discussion without identifying an approved finished product, particle specification or pharmacy supply.

Provider review

Cleveland Clinic micronized progesterone review: bioidentical describes less than a label

Cleveland’s specialized women’s health page names bioidentical therapy. Chemical identity, manufacturing, inactive ingredients and the formulation offered to a patient remain separate questions.

Provider review

Mayo Clinic micronized progesterone review: a consultation topic is not a product endorsement

Mayo includes questions about bioidentical hormones in its menopause consultation remit. That invitation does not identify a brand, approve every formulation or establish a pharmacy offer.

Provider review

Johns Hopkins micronized progesterone review: when an educational term needs a second definition

An institutional menopause article uses bioidentical language within an alternative-therapy discussion. That wording does not define a regulated product or identify what the separate clinical service prescribes.

Provider review

Mount Sinai micronized progesterone review: the hormone name leaves the formulation open

A dated Mount Sinai educational interview names progesterone, while the current service information confirms menopause care. Neither supplies an exact micronized product offer.

Provider review

Northwestern Medicine micronized progesterone review: off-label describes a use, not a formula

Northwestern lists off-label options within its menopause program. The term needs a named drug and proposed use before it says anything precise about a progesterone decision.

Provider review

UCLA Health micronized progesterone review: FDA-approved still needs an exact name

UCLA’s educational article recommends an FDA-approved category but does not identify a progesterone product supplied through its menopause program. Regulatory status, chemical identity and route remain distinct.

Provider review

Stanford Health Care micronized progesterone review: progesterone is not the entire progestogen category

Stanford names progesterone in a treatment explanation. The hormone identity should be preserved without assigning a particular micronized formulation or importing results from another active ingredient.

Provider review

University of Utah Health micronized progesterone review: conventional and compounded are separate records

Utah’s postmenopause education distinguishes conventional bioidentical medicines from compounded options. The distinction helps frame approval questions without identifying a product prescribed by its midlife service.

Guide

Oral Micronized Progesterone After Menopause: What a 12-Week Hot-Flash Trial Measured

A randomized trial found a lower combined frequency-and-severity score with oral progesterone than placebo. The result concerns selected healthy women, score units rather than episode counts, and a use not established by the US Prometrium label.

Guide

Oral Micronized Progesterone in Perimenopause: An Inconclusive Symptom Trial With Sleep Signals

A randomized Canadian study of 189 women found no statistically significant advantage on its primary hot-flash and night-sweat score. Participants reported better sleep and fewer night sweats on secondary questionnaires—a distinction that matters when interpreting progesterone claims.